Stegall leaves Dudnyk and takes new role at Group DCA

Allen Stegall has left his role as president of Dudnyk Healthcare Group, Horsham, Pa., and joined Group DCA, an online healthcare communications company, as vice president of electronic publishing and market research.
Stegall, a veteran healthcare marketer, brings 22 years of experience to Group DCA. He began his career at Pfizer as a sales representative and later worked at both Rhone Poulenc Rorer and ICI Pharma in various marketing roles before moving over to the agency side of the industry.
Stegall spent eight years on the West coast where he led BioGenesis Communications. Under Stegall's watch, BioGenesis launched several of the most successful biotech products, including Rituxan and Viracept.
Group DCA, formerly Dot Com Advisors, is a privately owned company that was established in 1999.
You must be a registered member of MMM to post a comment.

Next Article in Careers

Email Newsletters

Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.